The invention relates to hexahydro-1H-indeno/1,2-b/pyridines and a process for their manufacture. These compounds and the physiologically tolerable salts thereof are useful as agents for the treatment of psychic diseases.
Antidepressantly active 5-(4-aminophenyl)-hexahydro-1H-indeno-(1,2-b)pyridine